Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Testosterone may slow down wound healing and increase inflammation.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

The method effectively detects banned substances in urine for sports antidoping.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

No definitive link between finasteride and male breast cancer, but further research is needed.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.